Elite Pharmaceuticals, Inc. Restricted Cash and Investments, Noncurrent
Elite Pharmaceuticals, Inc. (ELTP) had Restricted Cash and Investments, Noncurrent of $496.90 thousand as of 2022-12-31, per its 10-Q filed 2023-02-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Investments, Noncurrent
us-gaap:RestrictedCashAndInvestmentsNoncurrent · last filed 2023-02-14
- 2022-12-31: Restricted Cash and Investments, Noncurrent $496.90K.
- 2022-09-30: Restricted Cash and Investments, Noncurrent $496.90K.
- 2022-06-30: Restricted Cash and Investments, Noncurrent $696.90K.
- 2022-03-31: Restricted Cash and Investments, Noncurrent $496.78K.
| Period end | Restricted Cash and Investments, Noncurrent |
|---|---|
| 2022-12-31 | $496.90K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $496.90K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $696.90K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $496.78K 10-Q · filed 2023-02-14 |
| 2021-12-31 | $769.59K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $769.58K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $496.75K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $496.75K 10-K · filed 2022-06-29 |
| 2020-03-31 | $480.34K 10-K · filed 2021-06-14 |